Key facts
- UniteLabs’s last known valuation is $1.2M (Oct 2022).
- It has raised $4.1M; the latest was Seed Round ($2.9M) in Mar 2025.
- Notable investors include Venture Kick, Atlantis Ventures, LANA Ventures, Acurio Ventures Partners, Basel Area Business & Innovation — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for UniteLabs
- ·The full record, as it builds
Funding rounds
No funding rounds for UniteLabs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About UniteLabs
Developer of an automation infrastructure platform designed for AI-driven lab automation in life science. The company's platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendors by offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment, enabling research facilities to automate and optimize experimental processes through real-time control, allowing the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.
- Sector
- Information Technology
- HQ
- Munich, Germany
- Founded
- 2017
- Employees
- 15
- Website
- unitelabs.io/
- Ownership
- Privately Held (backing)
UniteLabs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in UniteLabs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on UniteLabs in its N-PORT filings yet. We sweep new filings monthly.